Kanta Subbarao Indian virologist and physician
Subbarao, Kanta
VIAF ID: 58541361 (Personal)
Permalink: http://viaf.org/viaf/58541361
Preferred Forms
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| H5N1 influenza, 2007: |
|
| Locally Acquired Human Infection with Swine-Origin Influenza A(H3N2) Variant Virus, Australia, 2018 |
|
| Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine |
|
| Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells |
|
| The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines |
|
| Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models |
|
| Memory CD4+ T cells: beyond "helper" functions |
|
| Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans. |
|
| Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease |
|
| Molecular epidemiology of influenza A(H3N2) virus reinfections |
|
| A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice |
|
| The mouse model for influenza |
|
| Moving On Out: Transport and Packaging of Influenza Viral RNA into Virions |
|
| Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. |
|
| The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals |
|
| Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice |
|
| Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein |
|
| New options to treat influenza B. |
|
| Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge |
|
| The Ongoing Battle Against Influenza: The challenge of flu transmission |
|
| An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults |
|
| Passive immunization with influenza haemagglutinin specific monoclonal antibodies |
|
| Pathogenesis, humoral immune responses and transmission between co-housed animals in a ferret model of human RSV infection |
|
| The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon |
|
| Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2. |
|
| pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN |
|
| Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice |
|
| Postexposure prophylaxis for measles in a neonatal intensive care unit |
|
| Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies |
|
| Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza |
|
| Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines |
|
| Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons |
|
| Reassortment and evolution of current human influenza A and B viruses |
|
| Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. |
|
| Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. |
|
| Replication and immunogenicity of swine, equine, and avian h3 subtype influenza viruses in mice and ferrets |
|
| Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. |
|
| Respiratory syncytial virus-specific immunoglobulins in preterm infants |
|
| Respiratory virus infections: Understanding COVID-19 |
|
| Roadblocks to translational challenges on viral pathogenesis |
|
| Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults |
|
| The Role of Animal Models In Influenza Vaccine Research |
|
| Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets |
|
| Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model |
|
| SARS-CoV-2: A New Song Recalls an Old Melody |
|
| SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism |
|
| SARS vaccine protective in mice |
|
| Scientific barriers to developing vaccines against avian influenza viruses. |
|
| Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume. |
|
| A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice |
|
| The soft palate is an important site of adaptation for transmissible influenza viruses |
|
| Soft-Tissue Infections Caused by Mycobacterium fortuitum Complex Following Penetrating Injury |
|
| Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 |
|
| Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions |
|
| Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies |
|
| Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody |
|
| Systems biology of vaccination for seasonal influenza in humans |
|
| A Tale of Two Mutations: Beginning to Understand the Problems with Egg-Based Influenza Vaccines? |
|
| The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A |
|
| Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters |
|
| Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets. |
|
| Transmission studies resume for avian flu. |
|
| Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV) |
|
| Vaccines for pandemic influenza |
|
| Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques |
|
| Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers |
|
